Insights from Bacillus anthracis strains isolated from permafrost in the tundra zone of Russia.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 28 11 2018
accepted: 07 05 2019
entrez: 23 5 2019
pubmed: 23 5 2019
medline: 15 1 2020
Statut: epublish

Résumé

This article describes Bacillus anthracis strains isolated during an outbreak of anthrax on the Yamal Peninsula in the summer of 2016 and independently in Yakutia in 2015. A common feature of these strains is their conservation in permafrost, from which they were extracted either due to the thawing of permafrost (Yamal strains) or as the result of paleontological excavations (Yakut strains). All strains isolated on the Yamal share an identical genotype belonging to lineage B.Br.001/002, pointing to a common source of infection in a territory over 250 km in length. In contrast, during the excavations in Yakutia, three genetically different strains were recovered from a single pit. One strain belongs to B.Br.001/002, and whole genome sequence analysis showed that it is most closely related to the Yamal strains in spite of the remoteness of Yamal from Yakutia. The two other strains contribute to two different branches of A.Br.008/011, one of the remarkable polytomies described so far in the B. anthracis species. The geographic distribution of the strains belonging to A.Br.008/011 is suggesting that the polytomy emerged in the thirteenth century, in combination with the constitution of a unified Mongol empire extending from China to Eastern Europe. We propose an evolutionary model for B. anthracis recent evolution in which the B lineage spread throughout Eurasia and was subsequently replaced by the A lineage except in some geographically isolated areas.

Identifiants

pubmed: 31116737
doi: 10.1371/journal.pone.0209140
pii: PONE-D-18-34064
pmc: PMC6530834
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0209140

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

JAMA. 2002 May 1;287(17):2236-52
pubmed: 11980524
J Clin Microbiol. 2006 Sep;44(9):3352-60
pubmed: 16954272
Brief Bioinform. 2016 Jan;17(1):154-79
pubmed: 26026159
PLoS One. 2009;4(3):e4813
pubmed: 19283072
Am J Primatol. 2006 Sep;68(9):928-33
pubmed: 16900500
Sci Rep. 2016 Jun 06;6:27311
pubmed: 27265371
J Appl Microbiol. 1999 Aug;87(2):204-7
pubmed: 10475949
Extremophiles. 2006 Aug;10(4):259-67
pubmed: 16550305
Rev Sci Tech. 2017 Dec;36(3):959-963
pubmed: 30160697
Science. 1971 Jun 25;172(3990):1303-7
pubmed: 4996306
Emerg Infect Dis. 2012 Aug;18(8):1307-13
pubmed: 22840345
Emerg Infect Dis. 2014 Jan;20(1):21-8
pubmed: 24520560
PLoS One. 2007 May 23;2(5):e461
pubmed: 17520020
Emerg Infect Dis. 2014 Feb;20(2):322-3
pubmed: 24447525
PLoS Pathog. 2006 Nov;2(11):e122
pubmed: 17121463
BMC Genomics. 2014 Apr 16;15:288
pubmed: 24734872
BMC Microbiol. 2006 Apr 06;6:33
pubmed: 16600037
BMC Microbiol. 2018 Sep 3;18(1):102
pubmed: 30176810
Sci Rep. 2016 May 26;6:25606
pubmed: 27228400
Nat Rev Microbiol. 2014 Jun;12(6):414-25
pubmed: 24814065
Rev Sci Tech. 2002 Aug;21(2):359-83
pubmed: 11974621
Transbound Emerg Dis. 2017 Jun;64(3):892-898
pubmed: 26671241
J Vet Sci. 2012 Dec;13(4):385-93
pubmed: 23271180
PLoS One. 2015 Aug 12;10(8):e0135346
pubmed: 26266934
Am J Trop Med Hyg. 2012 Apr;86(4):703-10
pubmed: 22492157
PLoS One. 2016 Feb 22;11(2):e0146216
pubmed: 26901621
Jpn J Infect Dis. 2011;64(4):345-8
pubmed: 21788715
PLoS One. 2014 Feb 13;9(2):e89112
pubmed: 24551231
Appl Environ Microbiol. 2006 May;72(5):3168-74
pubmed: 16672454
Am J Trop Med Hyg. 2007 Dec;77(6):1103-10
pubmed: 18165531
mSystems. 2017 Jun 27;2(3):
pubmed: 28680972
PLoS One. 2012;7(3):e32866
pubmed: 22438886
mBio. 2016 Sep 27;7(5):
pubmed: 27677796
Can J Vet Res. 1995 Oct;59(4):256-64
pubmed: 8548686
J Appl Microbiol. 1999 Aug;87(2):192-5
pubmed: 10475946
EBioMedicine. 2015 Oct 06;2(11):1613-8
pubmed: 26870786
Can Vet J. 1995 May;36(5):295-301
pubmed: 7773917
Vaccine. 2017 Nov 1;35(46):6283-6289
pubmed: 28988866
Emerg Infect Dis. 2011 Mar;17(3):387-94
pubmed: 21392428
mBio. 2017 Apr 25;8(2):
pubmed: 28442608
PLoS One. 2012;7(12):e52841
pubmed: 23300794
Health Policy Plan. 2015 Jul;30(6):804-12
pubmed: 25000963
Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4274-9
pubmed: 24591590
J Clin Pathol. 2003 Mar;56(3):182-7
pubmed: 12610093
PLoS One. 2014 Jun 05;9(6):e95131
pubmed: 24901417
Glob Health Action. 2011;4:
pubmed: 22114567
Nucleic Acids Res. 2015 Feb 18;43(3):e15
pubmed: 25414349

Auteurs

Vitalii Timofeev (V)

State Research Center for Applied Microbiology & Biotechnology (FBIS SRCAMB), Obolensk, Russia.

Irina Bahtejeva (I)

State Research Center for Applied Microbiology & Biotechnology (FBIS SRCAMB), Obolensk, Russia.

Raisa Mironova (R)

State Research Center for Applied Microbiology & Biotechnology (FBIS SRCAMB), Obolensk, Russia.

Galina Titareva (G)

State Research Center for Applied Microbiology & Biotechnology (FBIS SRCAMB), Obolensk, Russia.

Igor Lev (I)

State Research Center for Applied Microbiology & Biotechnology (FBIS SRCAMB), Obolensk, Russia.

David Christiany (D)

Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Univ. Paris-Sud, Université Paris-Saclay, Gif-sur-Yvette cedex, France.

Alexander Borzilov (A)

State Research Center for Applied Microbiology & Biotechnology (FBIS SRCAMB), Obolensk, Russia.

Alexander Bogun (A)

State Research Center for Applied Microbiology & Biotechnology (FBIS SRCAMB), Obolensk, Russia.

Gilles Vergnaud (G)

Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Univ. Paris-Sud, Université Paris-Saclay, Gif-sur-Yvette cedex, France.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH